Proteimax BIO Technology

Company Overview

Snapshot

Founded in December 2025, Proteimax BIO Technology operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the discovery and commercialization of naturally occurring intracellular peptides.

Business overview

Proteimax BIO Technology specializes in developing and commercializing biologically active peptide solutions for human and animal health. The company's core technology involves naturally occurring intracellular peptides, with its lead candidate, Pep19, formulated as a functional food ingredient to address visceral fat, metabolic markers, and sleep quality. Proteimax partners with manufacturers in the food, beverage, supplement, and animal health industries to integrate its proprietary peptides into differentiated products, serving markets focused on nutrition and wellness.

Company Intelligence Q&A

What is Proteimax BIO Technology's primary focus?

Proteimax BIO Technology discovers and commercializes naturally occurring intracellular peptides designed to address significant health and agricultural challenges.

What is the lead product candidate for Proteimax BIO Technology?

The company's lead peptide, Pep19, is formulated as a functional food ingredient aimed at reducing visceral fat, improving metabolic markers, and enhancing sleep quality.

Which markets does Proteimax BIO Technology target?

Proteimax BIO Technology targets human and companion animal health markets, partnering with food, beverage, supplement, and animal health manufacturers.

What stage of development is Proteimax BIO Technology's product in?

Proteimax BIO Technology's product is currently in the Clinical Trial stage, supported by extensive preclinical work and early-stage clinical data.

When was Proteimax BIO Technology founded?

Proteimax BIO Technology was founded in December 2025.